Using a modification of an estabished treatment protocol [33] (Fig 4A), we found that early administration of RANK-Fc (which blocks the RANKL-RANK interaction) significantly attenuated salivary gland tumor progression in the TG mouse group (Fig 4B and 4C). The gene discussed is TNFSF11; the disease is tumor of salivary gland.